The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 28, 2020
Filed:
Oct. 31, 2016
Hyundai Pharm Co., Ltd., Cheonan-si, Chungcheongnam-do, KR;
Jin Yang, Yongin-si, KR;
Jin Woong Kim, Suwon-si, KR;
Han Kyu Lee, Hwaseong-si, KR;
Jae Hyun Kim, Yongin-si, KR;
Chang Mo Son, Suwon-si, KR;
Kyu Hwan Lee, Ansan-si, KR;
Jeong Un Hwang, Suwon-si, KR;
Hyung Ho Choi, Suwon-si, KR;
Dae Hoon Kim, Seoul, KR;
Jae Keol Rhee, Hwaseong-si, KR;
HYUNDAI PHARM CO., LTD., Chungcheongnam-do, KR;
Abstract
The present invention relates to a cyclohexene derivative, a preparation method thereof, and a pharmaceutical composition for preventing or treating metabolic disease containing the cyclohexene derivative as an active ingredient. The cyclohexene derivative according to the present invention increases the intracellular activity of cyclic adenosine monophosphate (cAMP) by activating G protein-coupled receptor 119 (GPR-119) and simultaneously exhibits weight loss and hypoglycemic effects by inducing the release of glucagon-like peptide-1 (GLP-1), which is a neuroendocrine protein, and thus can be useful as a pharmaceutical composition for preventing or treating metabolic diseases such as obesity, type 1 diabetes, type 2 diabetes, inadequate glucose tolerance, insulin resistance, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, dyslipidemia and syndrome X.